Patrick C. Gedeon

1.1k total citations
29 papers, 768 citations indexed

About

Patrick C. Gedeon is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Patrick C. Gedeon has authored 29 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Immunology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Patrick C. Gedeon's work include CAR-T cell therapy research (18 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Immunotherapy and Immune Responses (8 papers). Patrick C. Gedeon is often cited by papers focused on CAR-T cell therapy research (18 papers), Monoclonal and Polyclonal Antibodies Research (10 papers) and Immunotherapy and Immune Responses (8 papers). Patrick C. Gedeon collaborates with scholars based in United States, Japan and Australia. Patrick C. Gedeon's co-authors include John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez, Darell D. Bigner, Carter M. Suryadevara, James E. Herndon, Gary E. Archer, Jeffry D. Madura, Duane A. Mitchell and Peter E. Fecci and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Patrick C. Gedeon

26 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick C. Gedeon United States 15 516 282 213 167 160 29 768
Vita S. Salsman United States 6 535 1.0× 279 1.0× 159 0.7× 154 0.9× 110 0.7× 9 660
Skyler P. Rietberg United States 7 779 1.5× 309 1.1× 324 1.5× 297 1.8× 175 1.1× 9 1.0k
Xuekai Zhu China 12 489 0.9× 247 0.9× 262 1.2× 174 1.0× 41 0.3× 23 723
Katrin Töpfer Germany 11 655 1.3× 536 1.9× 246 1.2× 105 0.6× 44 0.3× 12 896
Ana Kostić United States 15 484 0.9× 109 0.4× 283 1.3× 184 1.1× 59 0.4× 39 990
Christopher D. Chien United States 16 702 1.4× 302 1.1× 450 2.1× 172 1.0× 47 0.3× 32 1.1k
Maxim A. Moroz United States 11 275 0.5× 84 0.3× 190 0.9× 146 0.9× 52 0.3× 19 558
Caroline Arber United States 16 504 1.0× 343 1.2× 235 1.1× 132 0.8× 28 0.2× 30 762
Thomas Nerreter Germany 13 853 1.7× 327 1.2× 387 1.8× 322 1.9× 41 0.3× 24 1.1k
Matthew J. Frank United States 15 522 1.0× 247 0.9× 192 0.9× 106 0.6× 37 0.2× 72 767

Countries citing papers authored by Patrick C. Gedeon

Since Specialization
Citations

This map shows the geographic impact of Patrick C. Gedeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick C. Gedeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick C. Gedeon more than expected).

Fields of papers citing papers by Patrick C. Gedeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick C. Gedeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick C. Gedeon. The network helps show where Patrick C. Gedeon may publish in the future.

Co-authorship network of co-authors of Patrick C. Gedeon

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick C. Gedeon. A scholar is included among the top collaborators of Patrick C. Gedeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick C. Gedeon. Patrick C. Gedeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cordova, Anthony F., et al.. (2025). Targeting STING to generate therapeutic anti-tumor immunity. Cancer Cell. 44(2). 260–280.
2.
Sasaki, Nobunari, Mizuki Homme, Takahiko Murayama, et al.. (2024). RNA sensing induced by chromosome missegregation augments anti-tumor immunity. Molecular Cell. 85(4). 770–786.e7. 5 indexed citations
3.
Ramapriyan, Rishab, Jing Sun, Patrick C. Gedeon, et al.. (2023). The Role of Antibody-Based Therapies in Neuro-Oncology. Antibodies. 12(4). 74–74. 8 indexed citations
4.
Nakazawa, Seshiru, Toshiteru Nagashima, Patrick C. Gedeon, et al.. (2023). Anatomy of the lung revisited by 3D-CT imaging. PubMed. 8. 17–17. 5 indexed citations
5.
Nobili, Alberto, Aya Kobayashi, Patrick C. Gedeon, & Carl D. Novina. (2022). Clutch Control: Changing the Speed and Direction of CAR-T Cell Therapy. PubMed. 4(2). 52–59.
6.
Gedeon, Patrick C., et al.. (2020). GLP toxicology study of a fully-human T cell redirecting CD3:EGFRvIII binding immunotherapeutic bispecific antibody. PLoS ONE. 15(7). e0236374–e0236374. 3 indexed citations
7.
Gedeon, Patrick C., Carter M. Suryadevara, Bryan D. Choi, & John H. Sampson. (2019). The effect of adoptive transfer of ex vivo activated T cells on the efficacy and tumor penetrance of intravenously-administered CD3-engaging bispecific antibody.. Journal of Clinical Oncology. 37(8_suppl). 30–30. 1 indexed citations
8.
Gedeon, Patrick C., Teilo Schaller, Satish K. Chitneni, et al.. (2018). A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma. Clinical Cancer Research. 24(15). 3611–3631. 38 indexed citations
9.
Suryadevara, Carter M., Rupen Desai, Melissa L. Abel, et al.. (2018). Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma. OncoImmunology. 7(6). e1434464–e1434464. 85 indexed citations
10.
Asciutto, Eliana K., Patrick C. Gedeon, Ignacio J. General, & Jeffry D. Madura. (2016). Structure and Dynamics Study of LeuT Using the Markov State Model and Perturbation Response Scanning Reveals Distinct Ion Induced Conformational States. The Journal of Physical Chemistry B. 120(33). 8361–8368. 3 indexed citations
11.
Suryadevara, Carter M., Patrick C. Gedeon, Luis Sánchez-Pérez, et al.. (2015). Are BiTEs the “missing link” in cancer therapy?. OncoImmunology. 4(6). e1008339–e1008339. 58 indexed citations
12.
13.
Congdon, Kendra L., Patrick C. Gedeon, Carter M. Suryadevara, et al.. (2014). Epidermal growth factor receptor and variant III targeted immunotherapy. Neuro-Oncology. 16(suppl 8). viii20–viii25. 30 indexed citations
14.
Gedeon, Patrick C., Katherine A. Riccione, Peter E. Fecci, & John H. Sampson. (2014). Antibody-Based Immunotherapy for Malignant Glioma. Seminars in Oncology. 41(4). 496–510. 9 indexed citations
15.
Gedeon, Patrick C., Bryan D. Choi, John H. Sampson, & Darell D. Bigner. (2013). Rindopepimut. Drugs of the Future. 38(3). 147–147. 20 indexed citations
16.
Gedeon, Patrick C., Bryan D. Choi, Tiffany R. Hodges, et al.. (2013). An EGFRvIII-targeted bispecific T-cell engager overcomes limitations of the standard of care for glioblastoma. Expert Review of Clinical Pharmacology. 6(4). 375–386. 22 indexed citations
17.
Choi, Bryan D., Patrick C. Gedeon, Chien‐Tsun Kuan, et al.. (2013). Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis. Journal of Immunological Methods. 395(1-2). 14–20. 4 indexed citations
18.
Choi, Bryan D., Carter M. Suryadevara, Patrick C. Gedeon, et al.. (2013). Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma. Journal of Clinical Neuroscience. 21(1). 189–190. 92 indexed citations
19.
Gedeon, Patrick C., et al.. (2012). LeuT Conformational Sampling Utilizing Accelerated Molecular Dynamics and Principal Component Analysis. Biophysical Journal. 103(1). L1–L3. 27 indexed citations
20.
Gedeon, Patrick C., et al.. (2009). Molecular dynamics of leucine and dopamine transporter proteins in a model cell membrane lipid bilayer. Proteins Structure Function and Bioinformatics. 78(4). 797–811. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vita S. Salsman Breakdown of academic impact, for papers by Skyler P. Rietberg Breakdown of academic impact, for papers by Xuekai Zhu Breakdown of academic impact, for papers by Katrin Töpfer Breakdown of academic impact, for papers by Ana Kostić Breakdown of academic impact, for papers by Christopher D. Chien Breakdown of academic impact, for papers by Maxim A. Moroz Breakdown of academic impact, for papers by Caroline Arber Breakdown of academic impact, for papers by Thomas Nerreter Breakdown of academic impact, for papers by Matthew J. Frank
Rankless by CCL
2026